` ATRY (Atrys Health SA) vs DAX Index Comparison - Alpha Spread

A
ATRY
vs
D
DAX Index

Over the past 12 months, ATRY has underperformed DAX Index, delivering a return of -14% compared to the DAX Index's +19% growth.

Stocks Performance
ATRY vs DAX Index

Loading
ATRY
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ATRY vs DAX Index

Loading
ATRY
DAX Index
Difference
www.alphaspread.com

Performance By Year
ATRY vs DAX Index

Loading
ATRY
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Atrys Health SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Atrys Health SA
Glance View

Market Cap
201.8m EUR
Industry
Health Care

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

ATRY Intrinsic Value
3.64 EUR
Undervaluation 27%
Intrinsic Value
Price
A
Back to Top